Shun Mitsui

596 total citations
20 papers, 498 citations indexed

About

Shun Mitsui is a scholar working on Neurology, Molecular Biology and Cell Biology. According to data from OpenAlex, Shun Mitsui has authored 20 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 7 papers in Molecular Biology and 5 papers in Cell Biology. Recurrent topics in Shun Mitsui's work include Amyotrophic Lateral Sclerosis Research (8 papers), Cellular transport and secretion (5 papers) and Advanced Nanomaterials in Catalysis (4 papers). Shun Mitsui is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (8 papers), Cellular transport and secretion (5 papers) and Advanced Nanomaterials in Catalysis (4 papers). Shun Mitsui collaborates with scholars based in Japan, China and Poland. Shun Mitsui's co-authors include Toshihiro Yamase, Masazumi Eriguchi, Aya Ogata, Hironobu Yanagië, Tomoyuki Hisa, Eri Ishikawa, Shinji Hadano, Y Morishita, Keiji Hasumi and Asako Otomo and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and The FASEB Journal.

In The Last Decade

Shun Mitsui

18 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shun Mitsui Japan 8 300 222 88 68 67 20 498
C.K. Bruns United States 5 53 0.2× 197 0.9× 209 2.4× 193 2.8× 9 0.1× 5 621
Janet A. Graden United States 7 39 0.1× 113 0.5× 174 2.0× 173 2.5× 8 0.1× 7 521
Arun Kumar Mahato India 13 29 0.1× 51 0.2× 43 0.5× 94 1.4× 26 0.4× 33 422
Runze Chen China 15 246 0.8× 16 0.1× 28 0.3× 225 3.3× 14 0.2× 39 646
Sripadh Sharma United States 6 58 0.2× 122 0.5× 24 0.3× 61 0.9× 8 0.1× 8 611
Jingyi Peng China 16 166 0.6× 74 0.3× 6 0.1× 159 2.3× 16 0.2× 55 687
Xiaobing Xi China 14 174 0.6× 271 1.2× 5 0.1× 104 1.5× 11 0.2× 30 578
Christopher J. Love United States 11 101 0.3× 59 0.3× 20 0.2× 58 0.9× 18 0.3× 24 428
Shuyi Cai China 10 27 0.1× 180 0.8× 97 1.1× 107 1.6× 6 0.1× 14 450
Yue Xu China 17 102 0.3× 46 0.2× 11 0.1× 143 2.1× 33 0.5× 49 744

Countries citing papers authored by Shun Mitsui

Since Specialization
Citations

This map shows the geographic impact of Shun Mitsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shun Mitsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shun Mitsui more than expected).

Fields of papers citing papers by Shun Mitsui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shun Mitsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shun Mitsui. The network helps show where Shun Mitsui may publish in the future.

Co-authorship network of co-authors of Shun Mitsui

This figure shows the co-authorship network connecting the top 25 collaborators of Shun Mitsui. A scholar is included among the top collaborators of Shun Mitsui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shun Mitsui. Shun Mitsui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Chigure, Junji Yamaguchi, Shun Mitsui, et al.. (2024). Direct evidence for ultrastructures of the α-synuclein-associated synaptic vesicle pool in presynaptic terminals. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167494–167494.
3.
Mitsui, Shun, Asako Otomo, Eiji Warabi, et al.. (2022). SQSTM1, a protective factor of SOD1-linked motor neuron disease, regulates the accumulation and distribution of ubiquitinated protein aggregates in neuron. Neurochemistry International. 158. 105364–105364. 2 indexed citations
4.
Suzuki-Utsunomiya, Kyoko, et al.. (2022). Central nervous system specific high molecular weight ALS2/alsin homophilic complex is enriched in mouse brain synaptosomes. Biochemical and Biophysical Research Communications. 638. 168–175.
5.
Otomo, Asako, et al.. (2021). High-throughput quantitative analysis of axonal transport in cultured neurons from SOD1H46R ALS mice by using a microfluidic device. Neuroscience Research. 174. 46–52. 4 indexed citations
6.
Mitsui, Shun, et al.. (2021). The N-terminal intrinsically disordered region mediates intracellular localization and self-oligomerization of ALS2. Biochemical and Biophysical Research Communications. 569. 106–111. 5 indexed citations
7.
Otomo, Asako, et al.. (2020). ALS2, the small GTPase Rab17-interacting protein, regulates maturation and sorting of Rab17-associated endosomes. Biochemical and Biophysical Research Communications. 523(4). 908–915. 8 indexed citations
8.
Otomo, Asako, Shun Mitsui, Yongping Chen, et al.. (2020). SQSTM1L341V variant that is linked to sporadic ALS exhibits impaired association with MAP1LC3 in cultured cells. eNeurologicalSci. 22. 100301–100301. 5 indexed citations
9.
Otomo, Asako, Mahoko Takahashi Ueda, Kyoko Suzuki-Utsunomiya, et al.. (2020). Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2‐mediated endosomal function. The FASEB Journal. 34(S1). 1–1. 1 indexed citations
10.
Sakai, Kiyota, Shun Mitsui, Akitoshi ITO, et al.. (2019). Ability of Saccharomyces cerevisiae MC87-46 to assimilate isomaltose and its effects on sake taste. Scientific Reports. 9(1). 13908–13908. 7 indexed citations
11.
Mitsui, Shun, Asako Otomo, Hiroaki Adachi, et al.. (2018). Additional file 4: of Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1H46R-expressing ALS mouse model. Figshare. 1 indexed citations
12.
Mitsui, Shun, Asako Otomo, Hiroaki Adachi, et al.. (2018). Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1H46R-expressing ALS mouse model. Molecular Brain. 11(1). 30–30. 35 indexed citations
13.
Otomo, Asako, Mahoko Takahashi Ueda, Kyoko Suzuki-Utsunomiya, et al.. (2018). Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function. Journal of Biological Chemistry. 293(44). 17135–17153. 24 indexed citations
14.
Hadano, Shinji, Shun Mitsui, Lei Pan, et al.. (2016). Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice. Human Molecular Genetics. 25(15). 3321–3340. 50 indexed citations
15.
Shimizu, Motoyuki, Tatsuya Yamamoto, Kiyota Sakai, et al.. (2015). Novel 4-methyl-2-oxopentanoate reductase involved in synthesis of the Japanese sake flavor, ethyl leucate. Applied Microbiology and Biotechnology. 100(7). 3137–3145. 6 indexed citations
16.
Ogata, Aya, Hironobu Yanagië, Eri Ishikawa, et al.. (2007). Antitumour effect of polyoxomolybdates: induction of apoptotic cell death and autophagy in in vitro and in vivo models. British Journal of Cancer. 98(2). 399–409. 106 indexed citations
17.
Yanagië, Hironobu, Aya Ogata, Shun Mitsui, et al.. (2006). Anticancer activity of polyoxomolybdate. Biomedicine & Pharmacotherapy. 60(7). 349–352. 111 indexed citations
18.
Mitsui, Shun, Aya Ogata, Hironobu Yanagië, et al.. (2006). Antitumor activity of polyoxomolybdate, [NH3Pri]6[Mo7O24]·3H2O, against, human gastric cancer model. Biomedicine & Pharmacotherapy. 60(7). 353–358. 60 indexed citations
19.
Ogata, Aya, Shun Mitsui, Hironobu Yanagië, et al.. (2005). A novel anti-tumor agent, polyoxomolybdate induces apoptotic cell death in AsPC-1 human pancreatic cancer cells. Biomedicine & Pharmacotherapy. 59(5). 240–244. 69 indexed citations
20.
Satô, Akiko, et al.. (1980). ChemInform Abstract: MEVALONOLACTONE DERIVATIVES AS INHIBITORS OF 3‐HYDROXY‐3‐METHYLGLUTARYL COENZYME A REDUCTASE. Chemischer Informationsdienst. 11(45). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026